Multiple Myeloma

Stem cells have been used to treat diseases of the blood for many years. Listed below are some trials investigating the use of stem cells from bone marrow to assist patient recovery. Click on the link provided to find out more about this trial. It remains too early to know if this approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Multiple Myeloma

  • Quality of Life Assessment and Overall Survival in Patients with Mulitple Myeloma after Tandem Autologous Stem Cell Transplantation Location: Australia
    Overview: This trial is investigation the use of the patient's own stem cells in the treatment of patients with multiple myeloma. The trial is being conducted by the Haematology Department of Launceston General Hospital in Tasmania. This ongoing trial commenced in July 2007 and expects to recruit 40 patients. Participants will receive G-CSF injection five days prior to harvesting peripheral blood stem cells via apheresis. The peripheral blood stem cells will be divided into two samples. The first sample will be administered to the patient once they have received a dose of ablative chemotherapy. The second sample will be administered three months later, after another dose of ablative chemotherapy. Participants will be monitored for complications and assessed for changes in their clinical condition.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Adult Blood Stem Cells